Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83349509)
Watch
English
Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?
scientific article published on 01 February 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
editorial
0 references
title
Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
main subject
acute myeloid leukemia
0 references
author
Pellegrino Musto
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
author name string
Felicetto Ferrara
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
publication date
1 February 2011
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
volume
117
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
issue
17
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
page(s)
3879-3881
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
cites work
Clinically useful prognostic factors in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Age and acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute myelogenous leukemia in older adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25934
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.25934
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PubMed publication ID
21287537
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21287537
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
